QLGN Stock Earnings: Qualigen Therapeutics Reported Results for Q2 2024

    Date:

    Qualigen Therapeutics (NASDAQ:QLGN) just reported results for the second quarter of 2024.

    • Qualigen Therapeutics reported earnings per share of -20 cents.
    • The company did not report any revenue for the quarter.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Chart

    SignUp For Breaking Alerts

    New Graphic

    We respect your email privacy

    Share post:

    Popular

    More like this
    Related

    Options Market Expectations from the FOMC

    Finally, the long-awaited day arrives.  We seemingly have been...

    How to Get Started with the IBrokers Package

    Your Privacy When you visit any website it may use...

    FOMC May Spark Volatility Amidst Frail Seasonals: Sep. 18, 2024

    Investors are patiently awaiting this afternoon’s interest rate decision...

    The pecking order of 401(k) plan design: A bird’s eye view

    Establishing the optimal workplace retirement plan follows a pecking...